Rediken Laboratories Private Limited
Provides medical laboratory services.
2012 | Jabalpur, Madhya Pradesh (India) | Active
Rediken Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 3.16%
- Profit Growth 51.73%
- Ebitda 1395.57%
- Net Worth 13.22%
- Total Assets -3.53%
About Rediken Laboratories
Rediken Laboratories Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 2012 and has a history of 12 years and three months. Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 M.
Ram Patel, Manisha Patel, Anmol Patel, and One other member serve as directors at the Company.
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP2012PTC029596
- Company No.
029596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Healthcare
What products or services does Rediken Laboratories Private Limited offer?
Rediken Laboratories Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Diclofenac, Diclofenac Sodium Injection, Vitamin & Multivitamin Injections, Methylcobalamin Injection.
Who are the key members and board of directors at Rediken Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Patel  | Director | 29-Nov-2012 | Current |
| Manisha Patel | Director | 29-Nov-2012 | Current |
| Anmol Patel | Additional Director | 01-Apr-2024 | Current |
| Rakesh Patel | Director | 29-Nov-2012 | Current |
Financial Performance of Rediken Laboratories.
Rediken Laboratories Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.16% increase. The company also saw a substantial improvement in profitability, with a 51.73% increase in profit. The company's net worth Soared by an impressive increase of 13.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rediken Laboratories?
In 2019, Rediken Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2016 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Rediken Laboratories?
Unlock and access historical data on people associated with Rediken Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rediken Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rediken Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.